Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AB, T6G 2R3, Canada.
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2R3, Canada.
J Cardiovasc Transl Res. 2021 Jun;14(3):503-512. doi: 10.1007/s12265-020-10080-x. Epub 2020 Oct 21.
We aim to investigate whether structural valve deterioration (SVD) of bioprosthetic xenogenic tissue heart valves (XTHVs) is associated with increased immune cell infiltration and whether co-expression of several chemokines correlates with this increase in immune infiltrate. Explanted XTHVs from patients undergoing redo valve replacement for SVD were obtained. Immunohistochemical, microscopic, and gene expression analysis approaches were used. XTHVs (n = 37) were obtained from 32 patients (mean 67.7 years) after a mean time of 11.6 years post-implantation. Significantly increased immune cellular infiltration was observed in the explanted SVD valves for all immune cell types examined, including T cells, macrophages, B cells, neutrophils, and plasma cells, compared to non-SVD controls. Furthermore, a significantly increased chemokine gradient in explanted SVD valves accompanied immune cell infiltration. These data suggest the development of SVD is associated with a significantly increased burden of immune cellular infiltrate correlated to the induction of a chemokine gradient around the XHTV, representing chronic immune rejection.Graphical abstract Proposed interaction between innate and adaptive immunity leading to the development of structural valve deterioration in xenogenic tissue heart valves.
我们旨在研究生物假体异种组织心脏瓣膜(XTHV)的结构性瓣膜退化(SVD)是否与免疫细胞浸润增加有关,以及几种趋化因子的共表达是否与这种免疫浸润的增加相关。从因 SVD 而接受再次瓣膜置换的患者中获得了已植入的 XTHV。使用了免疫组织化学、显微镜和基因表达分析方法。从 32 名患者(平均 67.7 岁)中获得了 XTHV(n=37),平均在植入后 11.6 年。与非 SVD 对照相比,在所有检查的免疫细胞类型中,包括 T 细胞、巨噬细胞、B 细胞、中性粒细胞和浆细胞,在已植入的 SVD 瓣膜中观察到明显增加的免疫细胞浸润。此外,在已植入的 SVD 瓣膜中还伴随着免疫细胞浸润的趋化因子梯度明显增加。这些数据表明,SVD 的发展与围绕 XTHV 诱导的趋化因子梯度相关的显著增加的免疫细胞浸润负担有关,代表慢性免疫排斥反应。
图形摘要 拟议的先天免疫和适应性免疫之间的相互作用导致异种组织心脏瓣膜发生结构性瓣膜恶化。